Moreover, we have considered additional parameters of cellular health such as cell numbers and mitochondrial membrane potential to support the benefits of nucleoside supplementation in MDS fibroblasts with POLG, TWNK and DGUOK mutations. The gene discussed is POLG; the disease is myelodysplastic syndrome.